Every open market buy and sale of Ptc Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $56.2M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when PTCT insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an PTCT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every PTCT insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Mark Elliott BouldingExec. VP And Clo | Sale plan | 2,812 | $61.88 | $174K | 105,272 | Nov 18Form 4 |
| Oct 14, 2026 | Michael SchmertzlerDirector | Sale plan | 2,500 | $59.61 | $149K | 1,291,594 | Oct 16Form 4 |
| Oct 9, 2026 | Mark Elliott BouldingExec. VP And Clo | Sale plan | 192 | $64.26 | $12K | 105,272 | Oct 13Form 4 |
| Oct 7, 2026 | Michael SchmertzlerDirector | Sale plan | 2,500 | $63.39 | $158K | 1,294,094 | Oct 9Form 4 |
| Oct 6, 2026 | Mark Elliott BouldingExec. VP And Clo | Sale plan | 2,073 | $64.06 | $133K | 105,272 | Oct 7Form 4 |
| Sep 30, 2026 | Glenn Steele Jr Md PhdDirector | Sale plan | 12,000 | $65.16 | $782K | 22,500 | Oct 2Form 4 |
| Sep 17, 2026 | Michael SchmertzlerDirector | Sale plan | 20,000 | $67.49 | $1.3M | 1,296,594 | Sep 18Form 4 |
| Sep 10, 2026 | Michael SchmertzlerDirector | Sale plan | 20,000 | $67.59 | $1.4M | 1,316,594 | Sep 11Form 4 |
| Aug 27, 2026 | Michael SchmertzlerDirector | Sale plan | 25,000 | $72.26 | $1.8M | 1,336,594 | Aug 28Form 4 |
| Aug 20, 2026 | Michael SchmertzlerDirector | Sale plan | 25,000 | $72.22 | $1.8M | 1,361,594 | Aug 21Form 4 |
| Aug 17, 2026 | Mark Elliott BouldingExec. VP And Clo | Sale plan | 2,813 | $72.57 | $204K | 105,272 | Aug 19Form 4 |
| Aug 4, 2026 | Matthew B. KleinCEO | Sale plan | 10,292 | $68.57 | $706K | 383,868 | Aug 6Form 4 |
| Jul 14, 2026 | Pierre GravierCFO | Sale plan | 3,494 | $80.35 | $281K | 83,986 | Jul 16Form 4 |
| Jul 9, 2026 | Neil Gregory AlmsteadChief Technical Ops Officer | Sale plan | 2,464 | $90.25 | $222K | 60,299 | Jul 13Form 4 |
| Jul 9, 2026 | Mary L. SmithDirector | Sale plan | 15,834 | $90.00 | $1.4M | 21,813 | Jul 13Form 4 |
PTCT insider trading FAQ
Are PTCT insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of PTCT on the open market in 0 trades, and 13 sold $56.2M in 68 trades, 100% of that under pre-arranged trading plans.
When did an PTCT insider last buy shares?
There has been no open market insider purchase of PTCT in the last two years.
When did an PTCT insider last sell shares?
Mark Elliott Boulding (Exec. VP And Clo) sold 2,812 shares for $174K on Nov 16, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
